Finance

Stem cell research and development company announces grant

Published in Blood Weekly, February 10th, 2005

ReNeuron, the U.K.-based stem cell research and development company, announced that a consortium led by it has been awarded a UKP 2.2 million grant from the U.K. Department of Trade and Industry (DTI) under its technology program.

The grant will fund a 3-year stem cell bioprocessing project entitled "Therapeutic Products from Human Stem Cells." The aim of the project is to utilize the specific research, development and commercial expertise of the consortium members to develop and manufacture stem cell therapeutics for clinical and subsequent commercial application to address neurodegenerative diseases such as stroke, Huntington' disease and Parkinson disease.

...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (2005-02-10)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry